https://viralgen.com/resources/nedna-is-a-robust-alternative-to-plasmid-dna-for-aav-production2024-10-16https://viralgen.com/resources/overcoming-variability-and-scaling-challenges-in-aav-manufacturing2025-03-14https://viralgen.com/privacy-policy2025-07-31https://viralgen.com/manufacturing-platformshttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVialhttps://viralgen.com/hubfs/Manufacturing-platforms_chart_V2.svgManufacturingplatformschartV2ManufacturingplatformschartV22025-10-07https://viralgen.com/resources/navigating-variability-and-scalability-challenges-in-aav-production2025-03-14https://viralgen.com/insights/inversiones-para-la-creacion-de-un-nuevo-laboratorio-de-control-de-calidad-askbio-center-of-excellence-ace2024-09-27https://viralgen.com/resources/streamlining-advanced-therapy-medicinal-product-manufacturing-a-platform-approach-for-accelerating-gene-therapy-commercializationhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhDhttps://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage1https://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v1https://viralgen.com/hubfs/Screenshot%202024-09-24%20at%2010.28.29%20AM%201.pngScreenshot20240924at102829AM1Screenshot20240924at102829AM12025-10-03https://viralgen.com/news/viralgen-partners-vallabh-minikel-deverman-lab-broad-institute-gene-therapy-prion-disease2025-01-21https://viralgen.com/resources/outsourced-pharma-capacity-update-july-2025https://viralgen.com/hubfs/Brand%20Assets/Videos/Viralgen%20@%20OPCU%20-%20July%2017th%202025.mp4/medium.jpgViralgen Outsourced Pharma Capacity Update July 2025 - Fill/FinishDon't miss Viralgen's presentation at Outsourced Pharma's Cell & Gene Therapy Capacity Update, where CCO Andy Holt unveiled an exciting initiative that will accelerate data acquisition for investor funding. Watch now us to discover how Viralgen drives industry progress through innovation and strategic support.https://viralgen.com/hubfs/Brand%20Assets/Videos/Viralgen%20@%20OPCU%20-%20July%2017th%202025.mp41235nonohttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage1https://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhDhttps://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v12025-09-24https://viralgen.com/resources/addressing-the-complex-regulatory-environment-for-gene-therapieshttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v1https://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhDhttps://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage12025-01-17https://viralgen.com/insights/science-in-actionhttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/VRLG_2025%20Conference%20Recap_v1.gifVRLG2025ConferenceRecapv1VRLG2025ConferenceRecapv1https://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVial2026-01-28https://viralgen.com/resources/integrating-raman-spectroscopy-and-genome-scale-modeling-to-enhance-aav-upstream-manufacturinghttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhDhttps://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage1https://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v12025-07-23https://viralgen.com/cookies-policy2025-07-31https://viralgen.com/news/javier-garcia-receives-the-tambor-de-oro-20232024-09-30https://viralgen.com/process2026-03-18https://viralgen.com/resources/industry-takeaways-from-fdas-cell-and-gene-therapy-listening-sessionhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/Brand%20Assets/Videos/Viralgen%20@%20OPCU%20-%20July%2017th%202025.mp4/medium.jpgViralgen Outsourced Pharma Capacity Update July 2025 - Fill/FinishDon't miss Viralgen's presentation at Outsourced Pharma's Cell & Gene Therapy Capacity Update, where CCO Andy Holt unveiled an exciting initiative that will accelerate data acquisition for investor funding. Watch now us to discover how Viralgen drives industry progress through innovation and strategic support.https://viralgen.com/hubfs/Brand%20Assets/Videos/Viralgen%20@%20OPCU%20-%20July%2017th%202025.mp41235nonohttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhDhttps://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage1https://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v1https://viralgen.com/hubfs/GEN%20Webinar%20Panelists.svgGENWebinarPanelistsGENWebinarPanelists2025-10-24https://viralgen.com/insights/rare-disease-day-2025https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVialhttps://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V12026-01-23https://viralgen.com/resources/enhancing-cmc-regulatory-efficiency-in-gene-therapy2024-10-21https://viralgen.com/insights/rare-disease-day-2023https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V12024-09-27https://viralgen.com/news/viralgen-and-ctnnb1-foundation-partner-to-manufacture-a-new-gene-therapy-for-ctnnb1-syndromehttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/ESGCT%20AskBio%20PR%20Featured%20Image.pngESGCTAskBioPRFeaturedImageESGCTAskBioPRFeaturedImage2025-07-31https://viralgen.com/news/the-basque-national-orchestra-debutes-in-poland-with-a-tour-of-four-concerts2024-11-22https://viralgen.com/resources/webinar-making-a-meaningful-impact-in-aavhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/Brand%20Assets/Videos/Viralgen%20@%20OPCU%20-%20July%2017th%202025.mp4/medium.jpgViralgen Outsourced Pharma Capacity Update July 2025 - Fill/FinishDon't miss Viralgen's presentation at Outsourced Pharma's Cell & Gene Therapy Capacity Update, where CCO Andy Holt unveiled an exciting initiative that will accelerate data acquisition for investor funding. Watch now us to discover how Viralgen drives industry progress through innovation and strategic support.https://viralgen.com/hubfs/Brand%20Assets/Videos/Viralgen%20@%20OPCU%20-%20July%2017th%202025.mp41235nonohttps://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage1https://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v1https://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhD2025-11-03https://viralgen.com/insights/advanced-therapies-conference-recap-key-takeaways-from-key-cgt-fall-conferences2025-11-11https://viralgen.com/insights/viralgen-receives-cgmp-certification-to-produce-raav-commercial-grade-product-at-new-facility-in-san-sebastian-spain2024-09-26https://viralgen.com/resources/working-with-regulators-to-get-gene-therapies-to-more-patients2024-10-16https://viralgen.com/contact2026-01-27https://viralgen.com/resources/leveraging-historical-data-and-percentile-based-modeling-for-improved-aav-production-scalinghttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v1https://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage1https://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhD2025-07-23https://viralgen.com/insights/digital-transformation-at-viralgenhttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVialhttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V12025-07-31https://viralgen.com/resources/enhancing-the-upstream-performance-of-adeno-associated-virus-aav-vector-manufacturing-via-multivariate-data-analysishttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v1https://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage1https://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhD2025-07-23https://viralgen.com/personal-data-protection2025-07-31https://viralgen.com/facilitieshttps://viralgen.com/hubfs/03%20-%20Downstream%20Final.mp4/medium.jpgViralgen Downstream Suites03 - Downstream Finalhttps://viralgen.com/hubfs/03%20-%20Downstream%20Final.mp430nonohttps://viralgen.com/hubfs/02%20-%20Upstream%20Final.mp4/medium.jpgViralgen Upstream Suites02 - Upstream Finalhttps://viralgen.com/hubfs/02%20-%20Upstream%20Final.mp430nonohttps://viralgen.com/hubfs/07%20-%20Quality%20Control%20Final.mp4/medium.jpgViralgen Quality Control Labs07 - Quality Control Finalhttps://viralgen.com/hubfs/07%20-%20Quality%20Control%20Final.mp430nonohttps://viralgen.com/hubfs/05%20-%20Product%20Handling%20_%20Support%20Spaces%20Final.mp4/medium.jpgViralgen Product Handling & Support Space05 - Product Handling _ Support Spaces Finalhttps://viralgen.com/hubfs/05%20-%20Product%20Handling%20_%20Support%20Spaces%20Final.mp430nonohttps://viralgen.com/hubfs/06%20-%20Utility%20_%20Power%20Systems%20Final.mp4/medium.jpgViralgen Utility & Power Systems06 - Utility _ Power Systems Finalhttps://viralgen.com/hubfs/06%20-%20Utility%20_%20Power%20Systems%20Final.mp430nonohttps://viralgen.com/hubfs/04%20-%20Fill%20&%20Finish%20Final.mp4/medium.jpgViralgen Fill & Finish04 - Fill & Finish Finalhttps://viralgen.com/hubfs/04%20-%20Fill%20&%20Finish%20Final.mp430nonohttps://viralgen.com/hubfs/01%20-%20Cell%20Expansion%20Final.mp4/medium.jpgViralgen Cell Expansion Suites01 - Cell Expansion Finalhttps://viralgen.com/hubfs/01%20-%20Cell%20Expansion%20Final.mp430nonohttps://viralgen.com/hubfs/08%20-%20MSAT%20Final.mp4/medium.jpgViralgen Manufacturing, Science and Technology Laboratory08 - MSAT Finalhttps://viralgen.com/hubfs/08%20-%20MSAT%20Final.mp430nonohttps://viralgen.com/hubfs/home_1001-small%202%20(1).pnghome1001small21home1001small21https://viralgen.com/hubfs/Group%2091%20(1).pngGroup911Group9112025-08-01https://viralgen.com/news/viralgen-collaborates-with-trogenix-to-advance-aav-gene-therapy-for-gliobastomahttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/ESGCT%20AskBio%20PR%20Featured%20Image.pngESGCTAskBioPRFeaturedImageESGCTAskBioPRFeaturedImage2025-05-06https://viralgen.com/sustainability-policy2025-07-31https://viralgen.com/news/viralgen-inaugurates-its-new-msat-laboratory-in-donostia2024-09-26https://viralgen.com/news/apertura-gene-therapy-and-viralgen-announce-strategic-collaborationhttps://viralgen.com/hubfs/ESGCT%20AskBio%20PR%20Featured%20Image.pngESGCTAskBioPRFeaturedImageESGCTAskBioPRFeaturedImagehttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v112026-03-17https://viralgen.com/insights/viralgen-vector-core-s-l-leading-a-joint-effort-in-revolutionary-gene-therapy-advancements2024-09-27https://viralgen.com/insights/harnessing-ai-for-faster-and-more-efficient-development-manufacturing-of-life-changing-gene-therapieshttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/VRLG_2025%20Conference%20Recap_v1.gifVRLG2025ConferenceRecapv1VRLG2025ConferenceRecapv1https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVialhttps://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V12025-07-28https://viralgen.com/resources/breaking-through-the-challenges-of-raav-purity-characterization-by-ce-sds2024-11-18https://viralgen.com/information-security-policy2025-07-31https://viralgen.com/late-phase-productionhttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVial2025-07-31https://viralgen.com/resources/pioneering-raav-characterization-with-hts-technologieshttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhDhttps://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage1https://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v12025-01-17https://viralgen.com/resourceshttps://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v1https://viralgen.com/hubfs/Screenshot%202024-09-24%20at%2010.28.29%20AM%201.pngScreenshot20240924at102829AM1Screenshot20240924at102829AM1https://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage1https://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhD2025-01-24https://viralgen.com/resources/white-paper-a-proprietary-mammalian-suspension-technology-for-scalable-raav-production-the-pro10-cell-linehttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVialhttps://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v112025-03-14https://viralgen.com/es/insights/la-ia-como-catalizador-para-transformar-vidas-permitiendo-un-desarrollo-y-fabricacion-de-terapias-genicas-mas-veloz-y-eficaz2025-07-28https://viralgen.com/resources/facing-the-dual-scientific-and-financial-challenges-to-advance-cell-and-gene-therapieshttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVialhttps://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v112025-03-14https://viralgen.com/insights/viralgen-vector-core-and-elpida-therapeutics-partner-to-manufacture-gene-therapy-medicines-for-anticipated-spastic-paraplegia-50-spg50-and-charcot-marie-tooth-diseasehttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVial2024-11-22https://viralgen.com/news/visit-of-lehendakari-imanol-pradales-and-his-team-to-viralgen-facilitieshttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVial2024-11-22https://viralgen.com/ai-policy2026-03-17https://viralgen.com/resources/displacement-chromatography-for-enrichment-of-raav-genome-containing-capsids-using-weak-organic-acidhttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVialhttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v112024-11-22https://viralgen.com/early-phase-productionhttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVialhttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V12025-10-07https://viralgen.com/es/insights/transformaci%C3%B3n-digital-en-viralgenhttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVial2025-01-31https://viralgen.com/resources/optimizing-scale-up-to-2000l-in-upstream-processing2025-03-14https://viralgen.com/resources/leveraging-platform-and-process-characterization-data-to-accelerate-cgt-validation-and-commercializationhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage1https://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v1https://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhD2025-01-17https://viralgen.com/resources/improving-scalability-and-productivity-of-transient-transfection-aav-production2025-03-14https://viralgen.comhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/Viralgen%20Aava%20home%20page%20section_V1.mp4/medium.jpgViralgen Aava home page section_V1Viralgen Aava home page section_V1https://viralgen.com/hubfs/Viralgen%20Aava%20home%20page%20section_V1.mp41nonohttps://viralgen.com/hubfs/Brand%20Assets/Videos/Viralgen-Video-Clip-optimized.mp4/medium.jpgWell-equipped to advance your gene therapyServing as the world’s manufacturing center of excellence for AAV demands all the right resources be right at hand. And at Viralgen, they are. That uniquely positions us to help our clients find a more direct path to commercialization based on our proven science, new-fashioned thinking, focused capacity, and a true-to-target track record.https://viralgen.com/hubfs/Brand%20Assets/Videos/Viralgen-Video-Clip-optimized.mp413nonohttps://viralgen.com/hubfs/Viralgen%20Aava%20home%20page%20section_V1.webm/medium.jpgViralgen Aava home page section_V1Viralgen Aava home page section_V1https://viralgen.com/hubfs/Viralgen%20Aava%20home%20page%20section_V1.webm1nonohttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/Mendi_2.0%20mountain.pngMendi20mountainMendi20mountainhttps://viralgen.com/hubfs/Iturri_3.0%20spring.pngIturri30springIturri30spring2026-02-03https://viralgen.com/insights/visit-us-at-phacilitate-advanced-therapies-week-in-miamihttps://viralgen.com/hubfs/VRLG_2025%20Conference%20Recap_v1.gifVRLG2025ConferenceRecapv1VRLG2025ConferenceRecapv12024-09-27https://viralgen.com/insights/viralgen-at-the-asgct-26th-annual-meetinghttps://viralgen.com/hubfs/VRLG_2025%20Conference%20Recap_v1.gifVRLG2025ConferenceRecapv1VRLG2025ConferenceRecapv12024-09-30https://viralgen.com/resources/comparing-ultracentrifugation-versus-aex-for-successful-aav-purification2025-03-14https://viralgen.com/news/viralgen-welcomes-the-visit-of-alberto-nunez-feijoo-president-of-spain-s-partido-popular2024-09-26https://viralgen.com/resources/webinar-every-day-countshttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/Brand%20Assets/Videos/Viralgen%20@%20OPCU%20-%20July%2017th%202025.mp4/medium.jpgViralgen Outsourced Pharma Capacity Update July 2025 - Fill/FinishDon't miss Viralgen's presentation at Outsourced Pharma's Cell & Gene Therapy Capacity Update, where CCO Andy Holt unveiled an exciting initiative that will accelerate data acquisition for investor funding. Watch now us to discover how Viralgen drives industry progress through innovation and strategic support.https://viralgen.com/hubfs/Brand%20Assets/Videos/Viralgen%20@%20OPCU%20-%20July%2017th%202025.mp41235nonohttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhDhttps://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage1https://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v12025-12-12https://viralgen.com/process/aavahttps://viralgen.com/hubfs/VRLG-25-037%20-%20ESGCT%20_%20Aava%201003%201080p%20(1).mp4/medium.jpgVRLG-25-037 - ESGCT _ Aava 1003 1080p (1)VRLG-25-037 - ESGCT _ Aava 1003 1080p (1)https://viralgen.com/hubfs/VRLG-25-037%20-%20ESGCT%20_%20Aava%201003%201080p%20(1).mp495nonohttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/Iturri%20graphic%20v2%202.pngIturrigraphicv22Iturrigraphicv22https://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhDhttps://viralgen.com/hubfs/icon_predict%201.pngiconpredict1iconpredict1https://viralgen.com/hubfs/Section-Shape.pngSectionShapeSectionShapehttps://viralgen.com/hubfs/60%2B.svg6060https://viralgen.com/hubfs/Group.pngGroupGrouphttps://viralgen.com/hubfs/Group%20108.pngGroup108Group108https://viralgen.com/hubfs/Screenshot%202024-09-24%20at%2010.28.29%20AM%201.pngScreenshot20240924at102829AM1Screenshot20240924at102829AM1https://viralgen.com/hubfs/icon_deep%20data%201.pngicondeepdata1icondeepdata1https://viralgen.com/hubfs/100%25.svg100100https://viralgen.com/hubfs/what-we-do-gem-shape.pngwhatwedogemshapewhatwedogemshapehttps://viralgen.com/hubfs/100%25%205.svg10051005https://viralgen.com/hubfs/Group%20109.pngGroup109Group109https://viralgen.com/hubfs/41.svg4141https://viralgen.com/hubfs/Art%20shades.pngArtshadesArtshadeshttps://viralgen.com/hubfs/Digital%20-%20Website%2c%20Email%2c%20Social/Webpages/What%20We%20Do/Triple-Plasmid%20Transfection-1.pngTriplePlasmidTransfection1TriplePlasmidTransfection1https://viralgen.com/hubfs/Group%20107.pngGroup107Group107https://viralgen.com/hubfs/100%25%206.svg10061006https://viralgen.com/hubfs/icon_fast%201.pngiconfast1iconfast12026-03-23https://viralgen.com/insights/the-problem-of-partials-redefining-the-analytical-frameworks-surrounding-capsid-characterizationhttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhDhttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVialhttps://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V12026-03-11https://viralgen.com/resources/benefits-of-high-throughput-sequencing-based-methods-for-in-depth-characterization-of-recombinant-aav-productshttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage1https://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v1https://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhD2025-07-23https://viralgen.com/expert-insightshttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/Brand%20Assets/Videos/Viralgen%20@%20OPCU%20-%20July%2017th%202025.mp4/medium.jpgViralgen Outsourced Pharma Capacity Update July 2025 - Fill/FinishDon't miss Viralgen's presentation at Outsourced Pharma's Cell & Gene Therapy Capacity Update, where CCO Andy Holt unveiled an exciting initiative that will accelerate data acquisition for investor funding. Watch now us to discover how Viralgen drives industry progress through innovation and strategic support.https://viralgen.com/hubfs/Brand%20Assets/Videos/Viralgen%20@%20OPCU%20-%20July%2017th%202025.mp41235nonohttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nono2026-01-28https://viralgen.com/news/viralgen-and-axovia-partner-to-manufacture-an-investigational-gene-therapy-for-retinal-dystrophy-in-bardet-biedl-syndrome-bbs-patientshttps://viralgen.com/hubfs/ESGCT%20AskBio%20PR%20Featured%20Image.pngESGCTAskBioPRFeaturedImageESGCTAskBioPRFeaturedImagehttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v112025-01-22https://viralgen.com/resources/development-of-an-analytical-method-for-aav-capsid-protein-for-use-in-stability-studies2024-11-18https://viralgen.com/process-developmenthttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVial2025-10-07https://viralgen.com/resources/taav-and-viralgen-together-as-your-raav-manufacturing-solution2024-10-22https://viralgen.com/es/insights2025-01-31https://viralgen.com/resources/enhancing-aav6-vector-production-for-cell-therapies2024-10-16https://viralgen.com/resources/unlocking-efficiency-in-aav-manufacturing-with-doe-insightshttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v1https://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage1https://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhD2025-01-17https://viralgen.com/resources/boosting-aav-manufacturing-performance-with-multivariate-data-analysishttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v1https://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhDhttps://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage12025-01-17https://viralgen.com/resources/technology-transfer-process-excellence-with-an-aav-comparability-study2025-03-14https://viralgen.com/news/viralgen-joins-orphan-therapeutics-accelerator-clinical-development-network-as-a-manufacturing-partner-to-advance-rare-disease-therapieshttps://viralgen.com/hubfs/ESGCT%20AskBio%20PR%20Featured%20Image.pngESGCTAskBioPRFeaturedImageESGCTAskBioPRFeaturedImagehttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v112025-05-14https://viralgen.com/insights/successful-meeting-at-the-asgct-2023https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVialhttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V12024-11-22https://viralgen.com/news/susana-solis-perez-member-of-european-parliament-visited-viralgenhttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVialhttps://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v112024-11-22https://viralgen.com/resources/addressing-barriers-in-gene-therapy2025-03-14https://viralgen.com/insights/inversiones-para-la-creacion-de-un-nuevo-servicio-de-caracterizacion-de-proceso-de-fabricacion-industrial-de-vectores-virales-aav-msat2024-09-26https://viralgen.com/news/we-are-moving-towards-a-more-sustainable-future-with-solar-energyhttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVial2024-11-22https://viralgen.com/resources/adding-consistency-to-gene-therapy-manufacturing2024-10-16https://viralgen.com/news/askbio-announces-6-presentations-at-the-european-society-of-gene-and-cell-therapy-32nd-annual-meetinghttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/ESGCT%20AskBio%20PR%20Featured%20Image.pngESGCTAskBioPRFeaturedImageESGCTAskBioPRFeaturedImage2025-10-02https://viralgen.com/resources/exploring-key-regulatory-considerations-to-ensure-patient-safety-in-the-gene-therapy-spacehttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp4/medium.jpg10760_20251020115848541_gen_17thoct_1400et_od10760_20251020115848541_gen_17thoct_1400et_odhttps://viralgen.com/hubfs/10760_20251020115848541_gen_17thoct_1400et_od.mp43256nonohttps://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4/medium.jpgAndy Holt @ MOTM 2025Andy Holt @ MOTM 2025https://viralgen.com/hubfs/Andy%20Holt%20@%20MOTM%202025.mp4849nonohttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp4/medium.jpgLife Science Connect WebinarLife Science Connect Webinarhttps://viralgen.com/hubfs/Life%20Science%20Connect%20Webinar.mp42062nonohttps://viralgen.com/hubfs/VRLG_MotM%202025%20Webinar_1200x627_v1.gifVRLGMotM2025Webinar1200x627v1VRLGMotM2025Webinar1200x627v1https://viralgen.com/hubfs/Viralgen%20Webinar%20Ane%20Quesada%20PhD.gifViralgenWebinarAneQuesadaPhDViralgenWebinarAneQuesadaPhDhttps://viralgen.com/hubfs/VRLG%20GEN%20Webinar%20Oct%202025%20Feature%20Image%20(1).pngVRLGGENWebinarOct2025FeatureImage1VRLGGENWebinarOct2025FeatureImage12025-07-09https://viralgen.com/resources/optimizing-scale-up-of-aav-gene-therapy-in-upstream-processing2024-10-16https://viralgen.com/insightshttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVialhttps://viralgen.com/hubfs/VRLG%20RDD%202026%20Blog%20Featured%20Image.pngVRLGRDD2026BlogFeaturedImageVRLGRDD2026BlogFeaturedImagehttps://viralgen.com/hubfs/VRLG_2025%20Conference%20Recap_v1.gifVRLG2025ConferenceRecapv1VRLG2025ConferenceRecapv12025-01-24https://viralgen.com/what-we-dohttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVial2025-10-07https://viralgen.com/eventshttps://viralgen.com/hubfs/Viralgen%202026%20Hanson%20Wade%20Gene%20Therapy_V3.gifViralgen2026HansonWadeGeneTherapyV3Viralgen2026HansonWadeGeneTherapyV3https://viralgen.com/hubfs/Viralgen%202026%20Meeting%20on%20The%20Med_V3.gifViralgen2026MeetingonTheMedV3Viralgen2026MeetingonTheMedV3https://viralgen.com/hubfs/Viralgen%202026%20ASGCT_V3.gifViralgen2026ASGCTV3Viralgen2026ASGCTV32025-05-13https://viralgen.com/who-we-arehttps://viralgen.com/hubfs/Brand%20Assets/Videos/VIRALGEN-ESGCT-LOOP-4K.mp4/medium.jpgViralgen: ALL-IN AAVVIRALGEN-ESGCT-LOOP-4Khttps://viralgen.com/hubfs/Brand%20Assets/Videos/VIRALGEN-ESGCT-LOOP-4K.mp4106nonohttps://viralgen.com/hubfs/Mark%20Ellison.svgMarkEllisonMarkEllison2025-07-31https://viralgen.com/newshttps://viralgen.com/hubfs/ESGCT%20AskBio%20PR%20Featured%20Image.pngESGCTAskBioPRFeaturedImageESGCTAskBioPRFeaturedImagehttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v112025-01-24https://viralgen.com/insights/reflections-on-inclusion-and-diversity-with-sonia-guirado-from-eurofirms-foundationhttps://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVialhttps://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v112024-11-22https://viralgen.com/insights/rare-disease-day-2026https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4/medium.jpgLife Science In Action VIRALGEN 11_12 v3Life Science In Action VIRALGEN 11_12 v3https://viralgen.com/hubfs/Life%20Science%20In%20Action%20VIRALGEN%2011_12%20v3.mp4120nonohttps://viralgen.com/hubfs/PXL_20260227_114129669.jpegPXL20260227114129669PXL20260227114129669https://viralgen.com/hubfs/PXL_20260227_100401277.jpegPXL20260227100401277PXL20260227100401277https://viralgen.com/hubfs/VRLG%20Apertura%20Press%20Release_1200x627_v1.1.gifVRLGAperturaPressRelease1200x627v11VRLGAperturaPressRelease1200x627v11https://viralgen.com/hubfs/PXL_20260227_084423778.PORTRAIT.jpegPXL20260227084423778PORTRAITPXL20260227084423778PORTRAIThttps://viralgen.com/hubfs/VRLG-LSC%20Article_Resource_V1_LSC%20Article_Vial.jpgVRLGLSCArticleResourceV1LSCArticleVialVRLGLSCArticleResourceV1LSCArticleVialhttps://viralgen.com/hubfs/PXL_20260227_140911669.PORTRAIT.jpegPXL20260227140911669PORTRAITPXL20260227140911669PORTRAIThttps://viralgen.com/hubfs/Viralgen%20Science%20In%20Action%20blog_opt1_V1.gifViralgenScienceInActionblogopt1V1ViralgenScienceInActionblogopt1V1https://viralgen.com/hubfs/VRLG%20RDD%202026%20Blog%20Featured%20Image.pngVRLGRDD2026BlogFeaturedImageVRLGRDD2026BlogFeaturedImage2026-03-30